Xiromed is a vertically integrated generic pharmaceutical company focused on delivering high-quality and value products to the US and European markets. Our vision is to be a provider of high-quality generic pharmaceuticals that bring enhanced value to patients, customers, and the healthcare system. We aim to provide broad access to drug products across various dosage forms, therapeutic areas, and market channels. We continue to invest in state-of-the-art infrastructure across technology, manufacturing, and quality systems to build a diversified portfolio. Our greatest asset is our people, who embody passion, leadership, integrity, and a culture of success.
Bringing Xiromed EU portfolio pipeline, both internal and external, to the market in line with business goals and plans. This includes ensuring proper planning, technical preparation, timely implementation, and market launch.
Innovation, communication, teamwork, adaptability, productivity, sense of urgency, initiative, and problem-solving skills.
Xiromed, as part of the InsudPharma group, is committed to equal opportunities and treatment regardless of ethnicity, religion, age, sex, nationality, marital status, sexual orientation, gender identity, disability, or other personal or social circumstances, in accordance with current regulations.